Proteome Sciences plc (LON:PRM – Get Free Report)’s stock price was down 8.9% during mid-day trading on Wednesday . The stock traded as low as GBX 2.50 ($0.03) and last traded at GBX 2.73 ($0.04). Approximately 104,272 shares were traded during mid-day trading, a decline of 36% from the average daily volume of 162,162 shares. The stock had previously closed at GBX 3 ($0.04).
Proteome Sciences Price Performance
The business has a 50 day moving average of GBX 3.12 and a 200 day moving average of GBX 3.41. The firm has a market capitalization of £8.29 million, a price-to-earnings ratio of -281.00 and a beta of 0.07.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
See Also
- Five stocks we like better than Proteome Sciences
- How to Effectively Use the MarketBeat Ratings Screener
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- What is a Bond Market Holiday? How to Invest and Trade
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
